Home Blog Page 181

Blog

Pharma Marketing Blog

Most popular

I’m a Pundit, Yes I Am!

Pharma Guy - February 24, 2015

Pharma Companies Should Have Public Social Media Disclosure Policies, Survey Results...

Pharma Guy - October 8, 2009

Pharma Still Stinks, But Not as Much as Oil or Tobacco!

Pharma Guy - April 12, 2007

Web 2.0 for Pharma Marketing Podcast

Pharma Guy - January 10, 2007

CNTO411 Blog to Go Dark

Pharma Guy - January 20, 2009

Overcoming Pharma’s Employee Blogging Fears

Pharma Guy - March 6, 2008

Do Desperate Consumers Believe Cancer Drug DTC Ads?

Pharma Guy - August 12, 2016

Set Your Sights – A Novartis Facebook Connect App. Is It...

Pharma Guy - October 10, 2013

“We do things at Pfizer that are best for shareholders of...

Pharma Guy - July 14, 2012

Free Health Speech – Marketers, Reach for Your Gun!

Pharma Guy - January 8, 2009

1...180181182...240 Page 181 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026